A refreshing blackcurrant drink from New Zealand is poised to challenge coffee's dominance as the go-to beverage for concentration and performance. Notably, this innovative drink is also under study for its potential benefits to individuals with dementia.
Ārepa drinks and capsules are scientifically formulated using a combination of blackcurrants and pine bark. In its early stages, the company received support from Callaghan Innovation, allowing extensive research into the bio-active ingredients powering its products. These include Enzogenol, a patented pine bark extract, and the Neuroberry blackcurrant, harnessing the potency of anthocyanins—robust antioxidants.
Excitingly, last year, the company secured a significant supermarket contract in Australia, successfully placing its products on the shelves of both Coles and Woolworths. This achievement further solidifies the market impact and demand for Ārepa's exceptional offerings.
Photo: LEE XIE
Ārepa is currently being utilized in a study conducted by the University of Wollongong for the Dementia Australia Research Foundation. Kathryn engages in conversation with Sam Dodd, a reputable neuroscientist affiliated with the company.